Kynam Capital Management, LP Cogent Biosciences, Inc. Transaction History

Kynam Capital Management, LP

$1.18 Billion
Q3 2025

A detailed history of Kynam Capital Management, LP transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 7,886,172 shares of COGT stock, worth $265 Million. This represents 9.57% of its overall portfolio holdings.

Number of Shares

7,886,172

Previous 8,492,557 7.14%

Holding current value

$265 Million

Previous $61 Million 85.72%

% of portfolio

9.57%

Previous 7.28%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$7.17 - $14.36 $4.35 Million - $8.71 Million	-606,385 Reduced 7.14%	7,886,172 $113 Million
Q2 2025 Aug 14, 2025	SELL	$4.02 - $7.51 $2.46 Million - $4.6 Million	-612,443 Reduced 6.73%	8,492,557 $61 Million
Q4 2024 Feb 14, 2025	SELL	$7.64 - $12.28 $1.03 Million - $1.65 Million	-134,731 Reduced 1.46%	9,105,000 $71 Million
Q3 2024 Nov 14, 2024	SELL	$8.24 - $11.48 $170,188 - $237,107	-20,654 Reduced 0.22%	9,239,731 $99.8 Million
Q2 2024 Aug 14, 2024	BUY	$6.01 - $9.04 $4.57 Million - $6.87 Million	760,385 Added 8.95%	9,260,385 $78.1 Million
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $11.6 Million - $23.9 Million	2,645,234 Added 45.18%	8,500,000 $57.1 Million
Q4 2023 Feb 14, 2024	BUY	$4.06 - $10.08 $14.8 Million - $36.7 Million	3,644,641 Added 164.91%	5,854,766 $34.4 Million
Q3 2023 Nov 14, 2023	BUY	$9.69 - $13.34 $5.74 Million - $7.91 Million	592,734 Added 36.65%	2,210,125 $21.5 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $12 Million - $16.1 Million	1,217,417 Added 304.37%	1,617,391 $19.1 Million
Q1 2023 May 15, 2023	SELL	$10.04 - $15.5 $3.96 Million - $6.11 Million	-394,075 Reduced 49.63%	399,974 $4.32 Million
Q4 2022 Feb 14, 2023	SELL	$10.65 - $14.84 $2.04 Million - $2.84 Million	-191,106 Reduced 19.4%	794,049 $9.18 Million
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $139,394 - $252,216	-14,845 Reduced 1.48%	985,155 $14.7 Million
Q2 2022 Aug 15, 2022	BUY	$3.92 - $9.73 $3.92 Million - $9.73 Million	1,000,000 New	1,000,000 $9.02 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.7 $796,499 - $1.31 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $1.13 Million - $1.62 Million	150,000 New	150,000 $1.29 Million

Others Institutions Holding COGT

# of Institutions

214

Shares Held

133M

Call Options Held

999K

Put Options Held

429K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $2.21B
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Account

Kynam Capital Management, LP Cogent Biosciences, Inc. Transaction History